Using human‐specific primers, we determined mRNA levels of prostate‐specific antigen (PSA) or Kallikrein 3 (KLK3), considered a marker of androgenic activity in prostate and breast cancer cells (Magklara et al,2002; Attardi et al,2004). The gene discussed is KLK3; the disease is breast carcinoma.